HCPCS Level II
J0457
Injection, aztreonam, 100 mg
Codes near J0457
These sit next to J0457 in the CMS Level II file. All J codes
- J0395Injection, arbutamine hcl, 1 mg
- J0400Injection, aripiprazole, intramuscular, 0.25 mg
- J0401Injection, aripiprazole (abilify maintena), 1 mg
- J0402Injection, aripiprazole (abilify asimtufii), 1 mg
- J0456Injection, azithromycin, 500 mg
- J0458Injection, aztreonam/avibactam, 7.5 mg/2.5 mg (10 mg)
- J0461Injection, atropine sulfate, 0.01 mg
- J0462Injection, atropine sulfate, not therapeutically equivalent to j0461, 0.01 mg
- J0463Injection, atropine sulfate (fresenius and therapeutically equivalent), 0.01 mg
- J0470Injection, dimercaprol, per 100 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00003-2560-16 | Azactam | E.R. Squibb & Sons, L.L.C. | 100 |
| 00003-2570-16 | Azactam | E.R. Squibb & Sons, L.L.C. | 200 |
| 00409-0829-01 | Aztreonam | Pfizer Inc | 100 |
| 00409-0830-01 | Aztreonam | Pfizer Inc | 200 |
| 50090-7494-00 | Azactam | A-S Medication Solutions | 100 |
| 63323-0401-20 | Aztreonam | FreseniUS Kabi USA, LLC | 100 |
| 63323-0401-24 | Aztreonam | FreseniUS Kabi USA, LLC | 100 |
| 63323-0401-26 | Aztreonam | FreseniUS Kabi USA, LLC | 100 |
| 63323-0402-20 | Aztreonam | FreseniUS Kabi USA, LLC | 200 |
| 63323-0402-24 | Aztreonam | FreseniUS Kabi USA, LLC | 200 |
| 63323-0402-30 | Aztreonam | FreseniUS Kabi USA, LLC | 200 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.